Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001722024-20-000012
Filing Date
2020-08-25
Accepted
2020-08-25 18:36:17
Documents
1
Period of Report
2020-08-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159839496225044.html 4  
1 FORM 4 wf-form4_159839496225044.xml 4 7589
  Complete submission text file 0001722024-20-000012.txt   9189
Mailing Address 26 NORTH EUCLID AVENUE PASADENA CA 91101
Business Address 26 NORTH EUCLID AVENUE PASADENA CA 91101 626-578-0777
Alexandria Venture Investments, LLC (Reporting) CIK: 0001722024 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 201133736

Mailing Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)